Health Discovery Corporation
HDVY
$0.00
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -85.65% | 587.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -85.65% | 587.61% | |||
| Operating Income | 85.65% | -587.61% | |||
| Income Before Tax | 70.19% | -338.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 70.19% | -338.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 70.19% | -338.22% | |||
| EBIT | 85.65% | -587.61% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 70.73% | -355.56% | |||
| Normalized Basic EPS | 87.50% | -500.00% | |||
| EPS Diluted | 70.73% | -355.56% | |||
| Normalized Diluted EPS | 87.50% | -500.00% | |||
| Average Basic Shares Outstanding | 0.96% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.96% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||